A Comprehensive Analysis of Sequence Variants and Putative Disease-causing Mutations in Photoreceptor-specific Nuclear Receptor NR2E3

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2009 Nov 10

PMID 19898638

Citations 18

Authors

Atsuhiro Kanda

Anand Swaroop

Affiliations

Soon will be listed here.

Abstract

Purpose: The photoreceptor-specific orphan nuclear receptor NR2E3 is a key regulator of transcriptional events during photoreceptor differentiation in mammalian retina. Mutations in NR2E3 are associated with enhanced S-cone syndrome and related retinal phenotypes that reveal characteristic excess of S-cone function. This study was undertaken to determine biochemical as well as functional consequences of reported sequence variants and disease-causing mutations in NR2E3.

Methods: Twenty-five different mutations in the wild-type NR2E3 expression construct were generated by site-directed mutagenesis and performed nuclear localization, gel-shift, rhodopsin promoter activity assays, and co-immunoprecipitation in cultured mammalian cells.

Results: Of the 25 mutant proteins, 15 mislocalize at least partially to the cytoplasm. Eight of the nine changes in the DNA-binding domain (DBD) and 12 of the 14 mutations in the ligand-binding domain (LBD) of NR2E3 exhibited reduced DNA-binding and transcriptional activation of the rhodopsin promoter. Moreover, these mutations dramatically altered the interaction of NR2E3 with NRL as well as with CRX. Two NR2E3 variants between DBD and LBD showed no effect on any biochemical or functional parameter tested.

Conclusions: These data provide a better understanding of sequence variants, validate disease-causing mutations, and demonstrate the significance of DBD and LBD in mediating NR2E3 function. These studies contribute to molecular mechanisms underlying retinal phenotypes caused by NR2E3 mutations.

Citing Articles

Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53.

Wang Y, Kroll T, Hao L, Wen Z Cell Death Dis. 2025; 16(1):15.

PMID: 39809731 PMC: 11733144. DOI: 10.1038/s41419-025-07337-1.

Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.

Diakatou M, Dubois G, Erkilic N, Sanjurjo-Soriano C, Meunier I, Kalatzis V Int J Mol Sci. 2021; 22(5).

PMID: 33807610 PMC: 7961898. DOI: 10.3390/ijms22052607.

Novel Pathogenic Sequence Variants in and Clinical Findings in Three Patients.

Al-Khuzaei S, Broadgate S, Halford S, Jolly J, Shanks M, Clouston P Genes (Basel). 2020; 11(11).

PMID: 33138239 PMC: 7716234. DOI: 10.3390/genes11111288.

Enhanced S-Cone Syndrome: Spectrum of Clinical, Imaging, Electrophysiologic, and Genetic Findings in a Retrospective Case Series of 56 Patients.

de Carvalho E, Robson A, Arno G, Boon C, Webster A, Michaelides M Ophthalmol Retina. 2020; 5(2):195-214.

PMID: 32679203 PMC: 7861019. DOI: 10.1016/j.oret.2020.07.008.

Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.

Murro V, Mucciolo D, Sodi A, Passerini I, Giorgio D, Virgili G Graefes Arch Clin Exp Ophthalmol. 2018; 257(1):9-22.

PMID: 30324420 DOI: 10.1007/s00417-018-4161-z.

References

Bessant D, Payne A, Mitton K, Wang Q, Swain P, Plant C . A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet. 1999; 21(4):355-6. DOI: 10.1038/7678. View

Kanda A, Friedman J, Nishiguchi K, Swaroop A . Retinopathy mutations in the bZIP protein NRL alter phosphorylation and transcriptional activity. Hum Mutat. 2007; 28(6):589-98. DOI: 10.1002/humu.20488. View

Glass C, Rose D, Rosenfeld M . Nuclear receptor coactivators. Curr Opin Cell Biol. 1997; 9(2):222-32. DOI: 10.1016/s0955-0674(97)80066-x. View

Pachydaki S, Klaver C, Barbazetto I, Roy M, Gouras P, Allikmets R . Phenotypic features of patients with NR2E3 mutations. Arch Ophthalmol. 2009; 127(1):71-5. DOI: 10.1001/archophthalmol.2008.534. View

OBrien K, Cheng H, Jiang Y, Schulte D, Swaroop A, Hendrickson A . Expression of photoreceptor-specific nuclear receptor NR2E3 in rod photoreceptors of fetal human retina. Invest Ophthalmol Vis Sci. 2004; 45(8):2807-12. DOI: 10.1167/iovs.03-1317. View

Marmor M . Large rod-like photopic signals in a possible new form of congenital night blindness. Doc Ophthalmol. 1989; 71(3):265-9. DOI: 10.1007/BF00170975. View

Sohocki M, Sullivan L, Mintz-Hittner H, Birch D, Heckenlively J, Freund C . A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene. Am J Hum Genet. 1998; 63(5):1307-15. PMC: 1377541. DOI: 10.1086/302101. View

Wright A, Reddick A, Schwartz S, Ferguson J, Aleman T, Kellner U . Mutation analysis of NR2E3 and NRL genes in Enhanced S Cone Syndrome. Hum Mutat. 2004; 24(5):439. DOI: 10.1002/humu.9285. View

Nishiguchi K, Friedman J, Sandberg M, Swaroop A, Berson E, Dryja T . Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function. Proc Natl Acad Sci U S A. 2004; 101(51):17819-24. PMC: 535407. DOI: 10.1073/pnas.0408183101. View

10.

Hood D, Cideciyan A, Roman A, Jacobson S . Enhanced S cone syndrome: evidence for an abnormally large number of S cones. Vision Res. 1995; 35(10):1473-81. DOI: 10.1016/0042-6989(95)98727-q. View

11.

Roman A, Jacobson S . S cone-driven but not S cone-type electroretinograms in the enhanced S cone syndrome. Exp Eye Res. 1991; 53(5):685-90. DOI: 10.1016/0014-4835(91)90230-c. View

12.

Hollenberg S, Evans R . Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell. 1988; 55(5):899-906. DOI: 10.1016/0092-8674(88)90145-6. View

13.

Cheng H, Khanna H, Oh E, Hicks D, Mitton K, Swaroop A . Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors. Hum Mol Genet. 2004; 13(15):1563-75. DOI: 10.1093/hmg/ddh173. View

14.

Corbo J, Cepko C . A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome. PLoS Genet. 2005; 1(2):e11. PMC: 1186732. DOI: 10.1371/journal.pgen.0010011. View

15.

Jacobson S, Roman A, Roman M, GASS J, Parker J . Relatively enhanced S cone function in the Goldmann-Favre syndrome. Am J Ophthalmol. 1991; 111(4):446-53. DOI: 10.1016/s0002-9394(14)72379-7. View

16.

Nakamura Y, Hayashi T, Kozaki K, Kubo A, Omoto S, Watanabe A . Enhanced S-cone syndrome in a Japanese family with a nonsense NR2E3 mutation (Q350X). Acta Ophthalmol Scand. 2004; 82(5):616-22. DOI: 10.1111/j.1600-0420.2004.00328.x. View

17.

Kennan A, Aherne A, Humphries P . Light in retinitis pigmentosa. Trends Genet. 2005; 21(2):103-10. DOI: 10.1016/j.tig.2004.12.001. View

18.

Kim J, Lee M, Kim B, Kim J, Han S, Kim H . Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha. J Mol Endocrinol. 2005; 35(3):449-64. DOI: 10.1677/jme.1.01846. View

19.

Haider N, DeMarco P, Nystuen A, Huang X, Smith R, McCall M . The transcription factor Nr2e3 functions in retinal progenitors to suppress cone cell generation. Vis Neurosci. 2007; 23(6):917-29. DOI: 10.1017/S095252380623027X. View

20.

Rivolta C, Sharon D, Deangelis M, Dryja T . Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002; 11(10):1219-27. DOI: 10.1093/hmg/11.10.1219. View